Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses
- 1 September 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (3) , 417-423
- https://doi.org/10.1016/s0168-8278(98)80059-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Colchicine treatment of primary sclerosing cholangitisGastroenterology, 1995
- Primary Sclerosing CholangitisNew England Journal of Medicine, 1995
- A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitisGastroenterology, 1994
- Assessment for liver transplantation in patients with primary sclerosing cholangitisJournal of Hepatology, 1994
- Ursodeoxycholic Acid for Treatment of Primary Sclerosing Cholangitis: A Placebo–Controlled TrialHepatology, 1992
- Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot studyHepatology, 1991
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989
- Prospective trial of penicillamine in primary sclerosing cholangitisGastroenterology, 1988